Division of Rheumatology, Department of Internal Medicine, Uijeongbu Eulji Medical Center, Gyeonggi-do, Korea.
Division of Infectious Diseases, Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Korea.
Sci Rep. 2021 Apr 13;11(1):8080. doi: 10.1038/s41598-021-87668-z.
The objective of the study was to identify distinct patterns in inflammatory immune responses of COVID-19 patients and to investigate their association with clinical course and outcome. Data from hospitalized COVID-19 patients were retrieved from electronic medical record. Supervised k-means clustering of serial C-reactive protein levels (CRP), absolute neutrophil counts (ANC), and absolute lymphocyte counts (ALC) was used to assign immune responses to one of three groups. Then, relationships between patterns of inflammatory responses and clinical course and outcome of COVID-19 were assessed in a discovery and validation cohort. Unbiased clustering analysis grouped 105 patients of a discovery cohort into three distinct clusters. Cluster 1 (hyper-inflammatory immune response) was characterized by high CRP levels, high ANC, and low ALC, whereas Cluster 3 (hypo-inflammatory immune response) was associated with low CRP levels and normal ANC and ALC. Cluster 2 showed an intermediate pattern. All patients in Cluster 1 required oxygen support whilst 61% patients in Cluster 2 and no patient in Cluster 3 required supplementary oxygen. Two (13.3%) patients in Cluster 1 died, whereas no patient in Clusters 2 and 3 died. The results were confirmed in an independent validation cohort of 116 patients. We identified three different patterns of inflammatory immune response to COVID-19. Hyper-inflammatory immune responses with elevated CRP, neutrophilia, and lymphopenia are associated with a severe disease and a worse outcome. Therefore, targeting the hyper-inflammatory response might improve the clinical outcome of COVID-19.
本研究旨在确定 COVID-19 患者炎症免疫反应的独特模式,并探讨其与临床病程和结局的关系。从电子病历中检索了住院 COVID-19 患者的数据。采用基于监督的连续 C 反应蛋白(CRP)、绝对中性粒细胞计数(ANC)和绝对淋巴细胞计数(ALC)的 k-均值聚类,将免疫反应分为三组之一。然后,在发现和验证队列中评估炎症反应模式与 COVID-19 临床病程和结局的关系。无偏聚类分析将发现队列中的 105 例患者分为三个不同的簇。簇 1(高炎症免疫反应)的特点是 CRP 水平高、ANC 高、ALC 低,而簇 3(低炎症免疫反应)与 CRP 水平低、ANC 和 ALC 正常有关。簇 2 表现出中间模式。所有簇 1 患者均需要吸氧支持,而簇 2 患者中有 61%需要补充氧气,簇 3 患者则无需补充氧气。簇 1 中有 2 例(13.3%)患者死亡,而簇 2 和簇 3 中均无患者死亡。该结果在 116 例独立验证队列中得到了证实。我们确定了 COVID-19 炎症免疫反应的三种不同模式。高 CRP、中性粒细胞增多和淋巴细胞减少的高炎症免疫反应与严重疾病和不良结局相关。因此,针对高炎症反应可能改善 COVID-19 的临床结局。